Revolutionizing Mental Health Care at Home

In a compelling conversation with host Jared S. Taylor on Slice of Healthcare, Joseph Perekupka, CEO of Freespira, delved into the innovative mental health solutions his company is delivering. Freespira's approach is distinct: it's a non-medication PTSD treatment that patients complete at home in just 28 days. The treatment is particularly tailored for those dealing with panic disorders and PTSD — conditions that are often underdiagnosed or misunderstood.

Why PTSD and Panic Disorder?

Freespira chose to focus on these conditions not only because of their prevalence but also due to the lack of effective, non-pharmaceutical options. PTSD, commonly associated with combat veterans, is increasingly affecting civilians due to events like natural disasters and car accidents. Freespira steps in where medication may not be suitable or desired, offering a science-backed alternative focused on breathing regulation and self-guided healing.

The Role of the Care Specialist

Patients are supported throughout the 28-day treatment by dedicated care specialists — affectionately dubbed "Sherpas" by Joe. These specialists aren’t medical practitioners but guides who ensure the patients stick to their therapy schedule, understand their progress, and build lasting skills. A key feature is the visual feedback patients receive via a tablet, showing their breathing improvement over time, which enhances motivation and engagement.

Addressing Access and Affordability

Joe emphasized the systemic issues in behavioral health: 50% of Americans live in areas lacking sufficient mental health providers. Freespira bridges this gap with its home-based model. On the affordability front, the company is working directly with insurers to ensure the treatment is covered, reducing financial barriers and improving care equity.

Looking Forward: Regulation and Growth

Joe is optimistic about regulatory changes that may favor digital health solutions. He’s watching closely as policymakers push for equal approval and reimbursement paths for non-drug therapies. Freespira’s long-term goal is broad-based insurance reimbursement, making the treatment accessible across the U.S.

Powerful Patient Outcomes

Perhaps the most moving part of the conversation was Joe’s recounting of feedback from stakeholders — health plans, patients, and the Freespira team. Patients report life-changing experiences, from rejoining family activities to regaining independence. Health plans value the real-time clinical outcomes and patient satisfaction insights, which were previously hard to capture.